| mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
6e-08 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.25 |
3e-06 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |